Literature DB >> 23153983

Visfatin and its role in obesity development.

Jiri Stastny1, Julie Bienertova-Vasku, Anna Vasku.   

Abstract

Visfatin, a product of PBEF gene, is an adipocytokine that harbours strong insulin-mimetic activity and it has been reported previously to associate with obesity. Recent reports also provide evidence that Visfatin has also important intracellular effects as it is homologous with nicotinamide phosphoribosyltransferase (NAMPT). In this review, we summarize the main documented effects of Visfatin on metabolism in humans, with special emphasis put on the pathways associated with obesity.
Copyright © 2012 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23153983     DOI： 10.1016/j.dsx.2012.08.011

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN： 1871-4021


  18 in total

1.  Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma.

Authors:  Hai-Ping Zhang; Jian Zou; Zhuo-Qun Xu; Jun Ruan; Shu-Dong Yang; Ying Yin; Hui-Jun Mu
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

Review 2.  Childhood obesity: immune response and nutritional approaches.

Authors:  Thea Magrone; Emilio Jirillo
Journal:  Front Immunol       Date:  2015-02-24       Impact factor: 7.561

3.  Nampt/PBEF/visfatin serum levels: a new biomarker for retinal blood vessel occlusions.

Authors:  Simon Kaja; Anna A Shah; Shamim A Haji; Krishna B Patel; Yuliya Naumchuk; Alexander Zabaneh; Bryan C Gerdes; Nancy Kunjukunju; Nelson R Sabates; Michael A Cassell; Ron K Lord; Kevin P Pikey; Abraham Poulose; Peter Koulen
Journal:  Clin Ophthalmol       Date:  2015-04-07

Review 4.  Adipocytokines in renal transplant recipients.

Authors:  Kristof Nagy; Shankar Prasad Nagaraju; Connie M Rhee; Zoltan Mathe; Miklos Z Molnar
Journal:  Clin Kidney J       Date:  2016-03-15

5.  Strong association of the polymorphisms in PBEF1 and knee OA risk: a two-stage population-based study in China.

Authors:  Minjie Chu; Jiesheng Rong; Yidan Wang; Lin Zhu; Baifen Xing; Yuchun Tao; Xun Zhuang; Yashuang Zhao; Liying Jiang
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

6.  Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).

Authors:  Cordelia Manickam; Lynn Wachtman; Amanda J Martinot; Luis D Giavedoni; R Keith Reeves
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

7.  Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients.

Authors:  Chien-Yi Hsu; Po-Hsun Huang; Tz-Heng Chen; Chia-Hung Chiang; Hsin-Bang Leu; Chin-Chou Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Am J Hypertens       Date:  2015-08-22       Impact factor: 2.689

Review 8.  Perivascular fat, AMP-activated protein kinase and vascular diseases.

Authors:  T A M Almabrouk; M A Ewart; I P Salt; S Kennedy
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

9.  eNAMPT Is Localised to Areas of Cartilage Damage in Patients with Hip Osteoarthritis and Promotes Cartilage Catabolism and Inflammation.

Authors:  Ashleigh M Philp; Sam Butterworth; Edward T Davis; Simon W Jones
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 6.208

Review 10.  Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases.

Authors:  Rossana Scrivo; Massimiliano Vasile; Ulf Müller-Ladner; Elena Neumann; Guido Valesini
Journal:  Mediators Inflamm       Date:  2013-11-26       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.